Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted May 03, 2005 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

DTcuba.com

The Cuban vaccine against the Haemophilus influenzae B, the first of its kind obtained from synthetic antigens in the world, received the Gold Medal granted by the World Intellectual Property Organization.

The acknowledgement was received in this capital by Vicente Verez, director of the Center for Studies on Synthetic Antigens, which is attached to the Faculty of Chemistry of the University of Havana. Verez is also one of the creators of the vaccine.

According to experts, the vaccine was made using new procedures and a patented technology.

All Cuban children still on milk benefit from immunization against Haemophilus influenzae B, which kills 500,000 children under five years of age every year in the world.

The vaccine was developed in conjunction with the Genetic Engineering and Biotechnology Center, the Centro Nacional de Biopreparados, the Finlay Institute and the Pedro KourÝ Tropical Medicine Institute.

This is the sixth time that the World Intellectual Property Organization grants an award to Cuban products.

Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
A typical sugar plantation in Eastern Cuba
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy